Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $23.80 Analyst target: $49.00 Upside: 105.88%
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.